Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-dose triamcinolone injection for knee arthritis
NL-OMON21189Recruiting
- Sponsor
- Ziekenhuisgroep Twente
- Start
- Feb 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of triamcinolone in arthritis and rheumatoid arthritis (RA), sponsored by Ziekenhuisgroep Twente. Primary endpoint: Percentage of patients with sustained good response. Started Feb 2010; status: recruiting.
02
Drugs
triamcinolone
03
Conditions
arthritisrheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON21189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21189.